Search

everythinglearnresearchcommunity

for

Search:↓

The document says there are five types of hair loss conditions and different causes, including drugs.

Teloptosis is a key point in hair loss that could help in creating prevention-focused hair care strategies.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Chronic hair shedding may be caused by less variation in hair growth times and might stop on its own after several years.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Some people experienced temporary hair loss after hair transplant surgery but recovered fully within 10 months.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Higher levels of ischemia-modified albumin in telogen effluvium patients may indicate oxidative stress.

A systematic approach is crucial for managing hair loss in women.

Dermoscopy shows that diffuse alopecia areata progresses through specific hair growth stages.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.